Silicon Therapeutics

Woody Sherman joins Silicon Therapeutics as chief scientific officer

Monday, March 27, 2017

Silicon Therapeutics (Silicon Tx), an integrated computational drug discovery company creating novel small molecule therapeutics for difficult to target proteins, has announced the appointment of Woody Sherman Ph.D., as chief scientific officer to lead the development and application of its INSITE platform as STX continues its trajectory toward being the first truly integrated computational drug discovery company with massive physics-based simulations tightly integrated within their drug discovery and design workflows.

[Read More]